BRIEF published on 10/14/2025 at 07:05, 5 months 28 days ago Innate Pharma met en avant lacutamab lors d'un événement analystes et investisseurs Investisseurs Essai Clinique Innate Pharma Lacutamab Syndrome De Sézary
PRESS RELEASE published on 10/14/2025 at 07:00, 5 months 28 days ago Inside Information / Other news releases Innate Pharma to host analyst and investor event on Lacutamab on October 28, 2025. Event includes clinical perspectives, market outlook, and updates on Phase 3 trial and regulatory pathway for lacutamab Phase 3 Trial Investor Event Regulatory Pathway Innate Pharma Lacutamab
PRESS RELEASE published on 10/14/2025 at 07:00, 5 months 28 days ago Informations privilégiées / Autres communiqués Innate Pharma organise un événement analystes et investisseurs dédié à Lacutamab le 28 octobre 2025, mettant en lumière les perspectives cliniques et commerciales du produit Investisseurs Événement Innate Pharma Analystes Lacutamab
PRESS RELEASE published on 09/22/2025 at 13:41, 6 months 19 days ago Informations privilégiées / Communiqué sur comptes, résultats
PRESS RELEASE published on 09/17/2025 at 07:00, 6 months 24 days ago Informations privilégiées / Communiqué sur comptes, résultats
BRIEF published on 09/10/2025 at 10:35, 7 months 1 day ago Innate Pharma Annonce une Conférence Téléphonique pour ses Résultats Semestriels 2025 Résultats Financiers Immunothérapie Conférence Téléphonique Partenariats Biopharmaceutiques Innate Pharma
BRIEF published on 09/10/2025 at 10:35, 7 months 1 day ago Innate Pharma Announces 2025 Half-Year Results Conference Call Financial Results Conference Call Immunotherapy Innate Pharma Biopharmaceutical Partnerships
PRESS RELEASE published on 09/10/2025 at 10:30, 7 months 1 day ago Inside Information / Other news releases Innate Pharma schedules conference call and webcast for first half 2025 financial results and business update. Details for participation available on the company's website Financial Results Conference Call Business Update Webcast Innate Pharma
PRESS RELEASE published on 09/10/2025 at 10:30, 7 months 1 day ago Informations privilégiées / Autres communiqués Innate Pharma organise une conférence téléphonique pour présenter ses résultats financiers et l’avancée de son portefeuille au premier semestre 2025 Résultats Financiers Conférence Téléphonique Portefeuille Innate Pharma Biotechnologies
BRIEF published on 09/02/2025 at 07:05, 7 months 9 days ago Innate Pharma : Mise à jour sur le capital et les droits de vote Droits De Vote Actions AMF Immobilier Innate Pharma
Published on 04/11/2026 at 02:00, 20 hours 53 minutes ago Lobe Sciences Ltd. Announces Non-Brokered Private Placement
Published on 04/11/2026 at 01:40, 21 hours 13 minutes ago Arctic Fox Announces Closing of Final Tranche Of Non-Brokered Private Placement
Published on 04/11/2026 at 00:30, 22 hours 23 minutes ago Trans Canada Gold Corp. Announces Proposed Warrant Extension
Published on 04/10/2026 at 23:30, 23 hours 23 minutes ago Clean Air Metals Announces Management Changes
Published on 04/10/2026 at 23:15, 23 hours 38 minutes ago Gemdale Announces Change of Corporate Secretary
Published on 04/11/2026 at 16:45, 6 hours 7 minutes ago CGTN: One family: Xi Jinping stresses keeping future of cross-Strait ties in Chinese hands
Published on 04/11/2026 at 16:40, 6 hours 12 minutes ago VARON Delivers Advanced Portable Oxygen Concentrator to Meet Rising Demand in Europe
Published on 04/11/2026 at 16:30, 6 hours 22 minutes ago VARON Oxygen Concentrators Meet Rising Demand for Modern Oxygen Therapy in Germany
Published on 04/10/2026 at 19:00, 1 day 3 hours ago EPIC Suisse AG – Annual General Meeting 2026 approves all proposals by the Board of Directors
Published on 04/11/2026 at 16:29, 6 hours 24 minutes ago Décès de Madame Jacqueline Himsworth, Présidente du Conseil d’administration de Manitou Group
Published on 04/11/2026 at 16:29, 6 hours 24 minutes ago Passing of Madame Jacqueline Himsworth, Chairman of the Board of Directors of Manitou Group
Published on 04/10/2026 at 18:26, 1 day 4 hours ago EURAZEO ANNOUNCES THE SUCCESS OF ITS INAUGURAL 500 MILLION EURO BOND ISSUE
